Pharmacological Options for Smoking Cessation in Heavy-Drinking Smokers
about
A key role for the N/OFQ-NOP receptor system in modulating nicotine taking in a model of nicotine and alcohol co-administrationA Double-Blind Randomized Placebo-Controlled Trial of Oral Naltrexone for Heavy-Drinking Smokers Seeking Smoking Cessation Treatment.Nicotine-Use/Smoking Is Associated with the Efficacy of Naltrexone in the Treatment of Alcohol Dependence.
P2860
Pharmacological Options for Smoking Cessation in Heavy-Drinking Smokers
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh
2015年學術文章
@zh-hant
name
Pharmacological Options for Smoking Cessation in Heavy-Drinking Smokers
@ast
Pharmacological Options for Smoking Cessation in Heavy-Drinking Smokers
@en
type
label
Pharmacological Options for Smoking Cessation in Heavy-Drinking Smokers
@ast
Pharmacological Options for Smoking Cessation in Heavy-Drinking Smokers
@en
prefLabel
Pharmacological Options for Smoking Cessation in Heavy-Drinking Smokers
@ast
Pharmacological Options for Smoking Cessation in Heavy-Drinking Smokers
@en
P2093
P2860
P1433
P1476
Pharmacological Options for Smoking Cessation in Heavy-Drinking Smokers
@en
P2093
Lara A Ray
Megan M Yardley
Michael M Mirbaba
P2860
P2888
P304
P356
10.1007/S40263-015-0284-5
P577
2015-10-27T00:00:00Z